Vogt Frederick G bought IOVA
June 1, 2026 · Form 4 insider transaction
Vogt Frederick G bought 41,668 shares of Iovance Biotherapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
41,668
Price
$0.00
Total value
N/A
InsiderVogt Frederick G
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJune 1, 2026
Filing dateJune 3, 2026
Shares owned after571,206
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date.